This Issue Brief focuses on the changes over time in Marketplace insurance coverage in HealthCare.gov states and the association between various demographic and plan characteristics including income, metal level selection, race and ethnicity, and premiums by leveraging self-reported and imputed data.
Office of Health Policy (HP)
The Office of Health Policy (HP) provides a cross-cutting perspective that bridges Departmental programs, state, local, and private sector activities, and the research community, in order to develop, analyze, coordinate and inform leadership on health policy issues for the Secretary. HP carries out this mission by conducting policy and economic and budget analyses, assisting in the development and review of regulations, budgets, legislation, and survey design efforts, as well as conducting and coordinating research, evaluation, and information dissemination on issues relating to health policy.
HP is organized in four divisions that align with major Department programs:
Division of Health Care Financing Policy (HFP)
Division of Public Health Services (PHS)
Division of Health Care Quality and Outcomes (HQO)
Division of Health Care Access and Coverage (HAC)
Health Policy Research:
- Reports to Congress
- Research & Issue Briefs
- HP Authored or Sponsored Work Published in Journals
Other Helpful Information:
Topic Areas:
- Children's Health Insurance Program (CHIP)
- Data
- Evaluation
- Health & Health Care
- Health Indicators
- Health Care Coverage and Access
- Health Policy
- Healthcare Reform
- Healthcare Safety Net
- HIV & AIDS
- Medicaid
- Medicare
- Patient-Centered Outcomes Research Trust Fund (PCORTF)
- Prescription Drugs & Other Medical Products
- Public Health
- Uninsured & Underinsured
Contact Us: ASPEHealthPolicy@hhs.gov
Reports
Displaying 51 - 60 of 542. 10 per page. Page 6.
Advanced SearchASPE Issue Brief
Marketplace Enrollee Demographics, Plan Generosity, and Plan Premiums in HealthCare.gov States, 2015-2022
ASPE Issue Brief
Generic Drug Utilization and Spending Among Medicare Part D Enrollees in 2022
In 2022, 43.3 million Medicare Part D enrollees (82 percent) filled 1.1 billion prescriptions for generic prescription drugs. While most enrollees filled at least one prescription for $2 or less, most (54 percent) paid more than $2 for at least one generic drug. Over 6 million enrollees filled at least one prescription for over $20.
Fact Sheet
Inflation Reduction Act Research Series: Projected Impacts for Rural Medicare Enrollees
The Inflation Reduction Act (IRA) is helping people with Medicare, including over 8 million Part D enrollees who reside in rural areas. This fact sheet outlines the potential impacts of the IRA’s key drug-related provisions for rural Medicare enrollees.
ASPE Data Point
National Uninsured Rate Remains Largely Unchanged at 7.7 Percent in the Third Quarter of 2023
According to the most recent National Health Interview Survey data, the national uninsured rate in the third quarter of 2023 was 7.7 percent, unchanged statistically from the first two quarters of 2023.Related Products:
Database, Dataset
Final Report: Child and Caregiver Outcomes Using Linked Data
Child maltreatment and involvement in child welfare systems are well-known adverse childhood experiences associated with poor health outcomes during childhood and later in life. Very little is known about the health needs of, and services used by families involved in child welfare systems, particularly those services funded by Medicaid.
Report
Comparing Prescription Drugs in the U.S. and Other Countries: Prices and Availability
ASPE contracted with RAND Health Care to carry out three studies analyzing data on U.S. prescription drug prices and availability in comparison to drug prices and availability in other Organisation for Economic Co-operation and Development (OECD) countries. In 2022, U.S. prices across all drugs (brands and generics) were nearly 2.78 times as high as prices in the comparison countries. U.S.
ASPE Issue Brief
Medicare Enrollees and the Part D Drug Benefit: Improving Financial Protection through the Low-Income Subsidy
The Inflation Reduction Act’s (IRA) expanded financial assistance in Medicare’s Low-Income Subsidy (LIS) Program would have benefited nearly 461,000 Partial LIS enrollees had the provision been in effect in 2020. An additional 2.9 million Part D enrollees who were eligible but not enrolled in LIS would also have benefited from the program.
Report
Claims and Provider Payment Data Gaps for Responding to COVID-19
This report and accompanying discussion by ASPE and NORC highlights the claims data limitations identified during the COVID-19 Public Health Emergency Health (PHE) and provides considerations to address these limitations. The report identifies that limitations related to claims data were existing issues, exacerbated by, but not unique to, the COVID-19 PHE.
Fact Sheet
Inflation Reduction Act Research Series: Medicare Part B Inflation Rebates in 2023
The Inflation Reduction Act (IRA) includes provisions to increase accessibility and affordability of prescription drugs for the 65 million Medicare beneficiaries, reduce the rate of growth in Medicare drug spending, and improve the financial sustainability of the Medicare program. These IRA provisions include a rebate on certain Part B and D drug prices if prices rise faster than inflation.
Database, Dataset
State and Local Estimates of the Uninsured Population in the U.S. Using the Census Bureau’s 2022 American Community Survey
State and Local Estimates of the Uninsured Population in the U.S. Using the Census Bureau’s 2022 American Community SurveyMethodological Description